Top Gainers on Feb 25: Concord Biotech, Usha Martin, Jindal Saw


By Dalal Street Investment Journal (DSIJ)

Summary:


Concord Biotech, Usha Martin and Jindal Saw were among the top gainers in the Nifty 500 on February 25. Concord Biotech saw a 10x surge in volume compared with its 30-day average as the stock rebounded from a 52-week low. Usha Martin and Jindal Saw rallied on the back of sector tailwinds.

Concord Biotech and Usha Martin, Jindal Saw Rally Up to 12%: Here’s why

Concord Biotech

The pharma company Concord Biotech is the leading gainer among Nifty 500 companies. Its share price rose 12% on February 25 with robust volume. Volume jumped about 10x to 29.86 Lakh shares on the NSE, compared to the 30-day average of 3.33 lakh shares. This move followed a 55% downfall in the company’s share price from all-time levels.

This development followed a robust Q3FY26. Total revenue increased by 13.9% year-on-year to ₹277.8 crore, while EBITDA was flat at ₹99 crore, in comparison to ₹98 crore in the same period last quarter. Margin declined by 450 bps to 35.6%. Consolidated net profit fell 16% YoY to ₹63.7 crore.

Usha Martin

Usha Martin is another leading gainer among Nifty 500 companies. Its share price rose around 7% on February 25 with robust volume. Volume jumped over 10x to 65.75 Lakh shares on the NSE, compared to the 30-day average of 6.2 lakh shares. This move came on the back of a broad-based rally in steel sector companies.

The company's bottom line was robust during quarter three. Revenue from operations surged 6.6% year-on-year to ₹917.1 crore. Operating EBITDA expanded by 23.3% YoY to ₹176 crore, with the EBITDA margin improved to 19.2% in Q3FY26 from 16.6% in Q3FY25. PAT was up by 16.7% to ₹107.7 crore.

Usha Martin Ltd

Trade

425.7519.70 (4.85 %)

Updated - 25 February 2026
441.00day high
DAY HIGH
404.35day low
DAY LOW
9323469
VOLUME (BSE)

Jindal Saw

With a 6% gain, another steel player, Jindal Saw, is also among the top gainers. This surge also followed a jump in trading volume to 76.02 lakh, compared with the 5-day average of 17.18 lakh. This followed a CLSA note highlighting a sharp uptick in steel prices, which can increase earnings visibility and valuation for steel stocks. 

For Q3 FY26, the Company reported an order book of ~ $1,481 million for Iron & Steel Pipes and Pellets. Iron & Steel Pipes account for ~ $1,442 million and Pellets for ~ $39 million. The 

consolidated total income declined by 6.2% year-on-year to ₹4,963 crore in Q3FY26, due to headwind in the water segment. PAT fell by 48.2% to ₹248 crore.

Conclusion

Strong volumes accompanied sharp moves in Concord Biotech, Usha Martin, and Jindal Saw, signalling increased market participation. Concord Biotech recovered from a 52-week low, while sector tailwinds helped Usha Martin and Jindal Saw push higher.

About the Author

SEBI Registered Research Analyst (INH000006396).


Founded in 1986, Dalal Street Investment Journal (DSIJ) brings decades of experience in India’s equity markets. DSIJ's research combines fundamental analysis with price action, guided by disciplined risk management and capital preservation. They follow a structured, data-driven approach designed to help investors and traders make informed decisions beyond short-term market noise. 

Published Date : 25 Feb 2026

Disclaimer :

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.


Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,300+ Cr MTF Book

icon-with-text